CGM for Non-Diabetics: Do Healthy People Really Need One?

Continuous glucose monitors, or CGMs, used to be associated mainly with diabetes care.

That is no longer the case.

Over-the-counter CGMs have made continuous glucose data much easier for people without diabetes to access. In 2024, the U.S. Food and Drug Administration cleared Dexcom Stelo as the first OTC continuous glucose monitor. In June 2026, the FDA expanded Stelo's indication to people 2 years and older who do not use insulin.

At the same time, CGMs are increasingly being discussed as tools for metabolic health, nutrition, fitness, weight management, and everyday "glucose optimization."

The appeal is easy to understand.

Eat breakfast, check your glucose. Go for a walk, check again. Compare two meals and see which produces the smaller rise.

But having access to more glucose data raises a more important question:

If you are healthy and do not have diabetes, does wearing a CGM actually improve your health?

The best answer in 2026 is: sometimes the information may be useful, but the evidence does not support routine CGM use as necessary preventive healthcare for healthy people.

A major 2026 systematic review found that CGM may help with certain behavioral and glycemic outcomes in people without diabetes, particularly those with prediabetes. But healthy people with normal glucose regulation did not show the same clear glycemic benefit.

That does not mean CGMs are useless.

It means we need to separate what a CGM can measure from what current research has actually shown it can improve.

What Does a CGM Actually Measure?

A CGM uses a small sensor placed under the skin to estimate glucose levels in interstitial fluid, the fluid surrounding your cells.

Unlike a traditional blood test, which provides a snapshot at one point in time, a CGM can show how glucose changes throughout the day and around meals, physical activity, sleep, and other behaviors.

That makes CGM particularly interesting as a feedback tool.

Someone might notice, for example, that taking a walk after dinner changes their glucose pattern or that two breakfasts containing different foods produce different responses.

But a CGM reading should not automatically be treated as:

• a diagnosis;

• a complete score of metabolic health;

• evidence that a particular food is unhealthy;

• or proof that every glucose rise should be prevented.

CGM gives you more data.

It does not automatically tell you what every change means.

What Does the Latest 2026 Evidence Say?

One of the most important recent reviews was published in the European Journal of Medical Research in January 2026.

Researchers systematically evaluated CGM use in people without diabetes, examining effects on glucose control, body weight, dietary behavior, and lifestyle adherence.

The review included 23 studies involving 1,074 participants. Researchers searched the published literature through December 2025.

Overall, the results suggest that CGM may be useful as a biofeedback tool, but the benefits were not equally strong across all populations.

People with prediabetes appeared to have more room to benefit

Some evidence suggested improvements in glycemic measures among people with prediabetes.

That makes sense clinically: someone whose glucose regulation is already impaired may have more opportunity for measurable improvement when dietary or activity behaviors change.

Healthy people showed less clear benefit

Among healthy participants with normal glucose regulation, the review did not find an appreciable glycemic benefit comparable with that seen in higher-risk groups.

The review also did not establish CGM as a stand-alone weight-management intervention.

Instead, the authors concluded that CGM appears more promising as a precision biofeedback tool used within structured lifestyle interventions.

There is an important limitation, however.

The evidence base remains relatively small and heterogeneous. The included studies differed in their populations, study designs, interventions, and outcomes, and only part of the evidence could be combined quantitatively.

So the 2026 review is important—but it should not be interpreted as the final answer on CGM use in healthy people.

What Does the ADA Say About CGM in People Without Diabetes?

The American Diabetes Association strongly supports CGM for many people who already have diabetes.

That is different from recommending CGM as a screening tool for the general population.

The ADA's 2026 Standards of Care states that there is currently insufficient evidence to support CGM for screening or diagnosing prediabetes or diabetes.

The ADA continues to use established laboratory tests for screening and diagnosis, including:

• A1C;

• fasting plasma glucose;

• and a 2-hour plasma glucose measurement during a 75-g oral glucose tolerance test.

For nonpregnant individuals, the ADA defines prediabetes as:

• A1C: 5.7%–6.4%

• Fasting plasma glucose: 100–125 mg/dL

• 2-hour glucose during a 75-g OGTT: 140–199 mg/dL

This distinction matters because consumer CGM data can look extremely detailed.

You may see hundreds of readings and visually dramatic curves.

But an unusual CGM pattern does not by itself diagnose prediabetes.

Likewise, a smooth glucose curve does not prove that someone is metabolically healthy.

The Case for CGM Use in People Without Diabetes

There are reasonable arguments in favor of CGM use outside traditional diabetes care.

1. Immediate feedback can make lifestyle advice more tangible

Advice such as "take a walk after meals" or "pay attention to meal composition" can feel abstract.

Seeing how your own glucose responds may make the relationship between behavior and physiology easier to understand.

For some people, that feedback may improve engagement.

2. CGM can reveal repeated personal patterns

People do not necessarily respond identically to the same foods or behaviors.

A CGM can help someone observe patterns involving meals, exercise, timing, or daily routine that might otherwise be difficult to notice.

This does not mean every difference is clinically important.

But it can make CGM useful as a short-term learning tool.

3. People with prediabetes may have more actionable information

The strongest case outside diagnosed diabetes is probably not the completely healthy person chasing a perfectly flat glucose curve.

It is someone with an established metabolic risk factor, such as prediabetes, who is already making structured lifestyle changes.

The 2026 systematic review found more favorable evidence in people with prediabetes than in healthy participants with normal glucose regulation.

In that context, CGM may help turn general lifestyle advice into visible feedback.

The Case Against Routine CGM Use in Healthy People

The strongest argument against routine CGM use is not that the technology is worthless.

It is that more measurement does not automatically produce better health.

1. Long-term health benefits have not been established

A 2026 JAMA Internal Medicine Patient Page reviewing CGM use cautioned that good evidence showing improved health or diabetes prevention in people without diabetes is lacking.

That is different from showing that CGM can influence short-term behavior.

A person might change breakfast after seeing a glucose curve.

But that does not automatically prove that wearing a CGM will reduce their long-term risk of diabetes, cardiovascular disease, or other major health outcomes.

2. Healthy-person CGM targets are less clearly defined

Clinical CGM targets were developed largely in the context of diabetes management.

Healthy people often experience normal glucose variability throughout the day.

Trying to apply disease-management targets to every fluctuation in someone without diabetes can therefore lead to overinterpretation.

3. More data can create more anxiety

For some users, seeing every rise and fall may encourage useful experimentation.

For others, it may create unnecessary concern about normal biological variation.

The 2026 JAMA Patient Page highlighted potential downsides including attention and stress related to monitoring, as well as practical issues such as skin irritation, device malfunction, or sensors falling off.

The relevant question is therefore not simply:

"Can I measure my glucose?"

It is:

"Is this information helping me make better decisions?"

Are Glucose Spikes After Eating Always Bad?

No.

Glucose is expected to rise after eating carbohydrates.

A post-meal increase does not automatically mean that something is wrong.

This is one of the biggest problems with using CGM data without context: a graph can make normal physiology look like a medical event.

Different meals can produce different glucose responses. So can exercise, meal timing, sleep, stress, and many other variables.

What is much less certain is the clinical significance of every short-term glucose excursion in an otherwise healthy person.

That means a single "spike" should not automatically be interpreted as evidence that:

• the meal was unhealthy;

• insulin resistance is present;

• diabetes is developing;

• or the food should be eliminated.

Why Chasing a Perfectly Flat Glucose Curve Can Be Misleading

Imagine that an apple causes your glucose to rise more than a different snack.

If glucose response is the only thing you measure, you might conclude that the second food is "better."

But nutrition is not determined by one number.

Overall dietary quality also depends on factors such as:

• fiber;

• protein;

• micronutrients;

• energy intake;

• food processing;

• dietary pattern;

• cardiovascular risk;

• and whether the diet is realistic and sustainable.

A 2026 JAMA Internal Medicine Patient Page cautioned that focusing too heavily on glucose fluctuations could lead people without diabetes to unnecessarily avoid nutritious foods.

That is why "smaller glucose spike" and "healthier food" should not be treated as synonyms.

A CGM measures glucose.

It does not measure the total nutritional value of a meal.

Can a CGM Help With Weight Loss?

CGM is increasingly promoted in the context of weight management.

The theory is straightforward: if people can see how foods affect glucose, they may change what or how they eat.

Behavioral feedback may indeed be useful for some people.

But the evidence does not show that simply wearing a CGM causes meaningful weight loss.

The 2026 systematic review found that CGM was more promising for behavior modification than as an independent weight-management intervention.

That distinction is important.

A sensor may help support a behavior change.

It is not itself a weight-loss treatment.

And a smaller glucose response to a particular meal does not necessarily mean that the meal will produce greater fat loss.

Who Might Benefit From Trying a CGM?

For someone without diagnosed diabetes, CGM is most defensible when there is a specific question to answer.

It may be more useful for:

• someone with established prediabetes who is working on structured lifestyle changes;

• someone with relevant metabolic risk who is using CGM with professional guidance;

• someone who wants short-term feedback about repeatable behaviors such as meal composition or post-meal activity;

• or someone who can treat the information as experimental data rather than a daily health score.

In these cases, CGM can function as a learning tool.

The goal is not necessarily to wear one forever.

The goal is to identify useful patterns and determine whether those patterns translate into sustainable behaviors.

Who Probably Does Not Need Routine CGM Monitoring?

A healthy person with normal established glucose markers, no meaningful metabolic risk factors, and no specific question they are trying to answer has much less evidence supporting routine CGM use.

They can still choose to use one.

But interesting data are not the same as medically necessary data.

If the real concern is diabetes or prediabetes, established screening methods are more appropriate. The ADA specifically states that CGM is not currently supported as a diagnostic or screening substitute.

If the goal is general health, broader behaviors such as regular physical activity, an overall nutritious diet, adequate sleep, and appropriate preventive healthcare have a much stronger evidence base than attempting to optimize every short-term glucose fluctuation.

How to Use CGM Data Without Obsessing Over Every Spike

If you decide to try an OTC CGM, it helps to approach it like a structured experiment rather than a daily report card.

Look for repeated patterns

One unusual reading or one unusual meal tells you very little.

Look for patterns that occur consistently.

Compare similar situations

If you want to know whether a post-meal walk changes your glucose response, compare similar meals under similar conditions.

Changing five things at once makes the result much harder to interpret.

Focus on meaningful behaviors, not tiny differences

A five- or ten-point difference between two meals may look dramatic on a graph.

That does not necessarily mean it has meaningful long-term health consequences.

Do not judge foods by glucose alone

Consider the entire nutritional profile and your overall dietary pattern.

Do not use CGM data to diagnose yourself

If you repeatedly see unusual readings or are concerned about diabetes or prediabetes, established laboratory testing and professional medical evaluation are more appropriate.

The ADA's 2026 Standards explicitly states that evidence is currently insufficient to use CGM for screening or diagnosis.

So, Do Healthy People Really Need a CGM?

For most healthy people, a CGM is an optional information tool—not a necessary piece of preventive healthcare.

That does not make CGM useless outside diabetes.

The technology may provide useful short-term feedback, help some people engage more actively with lifestyle changes, and appear more relevant for people with prediabetes or other metabolic risks.

But the evidence is much weaker for metabolically healthy people whose glucose regulation is already normal.

The 2026 systematic review found that benefits varied by population and emphasized CGM's role as a biofeedback tool rather than a stand-alone intervention. The authors also worked with a relatively small and heterogeneous evidence base, so additional high-quality studies are still needed.

Meanwhile, the ADA does not recommend CGM as a replacement for established diabetes screening and diagnostic tests.

So if you are curious about your glucose, a short CGM experiment may teach you something useful.

Just keep the data in perspective.

A CGM can show you a glucose curve. It cannot tell you, by itself, whether you are healthy.

And the goal of nutrition should not be to create the flattest possible glucose line.

The goal is better overall health.

If you’re also exploring everyday nutrition approaches designed to support healthy glucose metabolism, you can learn more about our Glucose Support formula.

Frequently Asked Questions

Is CGM useful for people without diabetes?

It may be useful as a short-term biofeedback tool, especially for people with prediabetes or those using it as part of a structured lifestyle intervention. Current evidence is less convincing that routine CGM use improves glycemic health in otherwise healthy people with normal glucose regulation.

Can CGM diagnose prediabetes?

No. The ADA states that there is currently insufficient evidence to use CGM for screening or diagnosis of prediabetes or diabetes. Diagnosis relies on validated tests such as A1C, fasting plasma glucose, and oral glucose tolerance testing.

Is a glucose spike after eating unhealthy?

Not necessarily. Glucose normally rises after carbohydrate-containing meals. Individual post-meal glucose increases need to be interpreted in context, and the long-term significance of every CGM excursion in healthy people remains uncertain.

Can a CGM help with weight loss?

CGM may help some people change eating or activity behaviors, but current research does not establish it as a stand-alone weight-loss intervention.

Can healthy people buy an OTC CGM?

Yes. OTC CGMs are available in the United States. In June 2026, the FDA expanded Dexcom Stelo's OTC indication to people 2 years and older who do not use insulin. That regulatory clearance does not mean CGM is medically necessary for every eligible person.

References

1. Liao X, Li Y, Tang S, et al. Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis. European Journal of Medical Research. 2026;31:397.

2. American Diabetes Association Professional Practice Committee. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1).

3. Johansson M, Dower JA, Lipska KJ. Continuous Glucose Monitoring for Persons With and Without Diabetes. JAMA Internal Medicine. 2026;186(9):1182. doi:10.1001/jamainternmed.2026.2769.

4. U.S. Food and Drug Administration. FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children. June 12, 2026.

Medical Disclaimer: This article is for general educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease or replace individualized medical advice. If you are concerned about abnormal glucose, diabetes, prediabetes, medications, or symptoms related to high or low blood glucose, consult a qualified healthcare professional.